While this modest weight loss can provide health benefits, it is substantially less than what is achieved with prescription semaglutide
The fix: Start with low-fermentation options (psyllium, methylcellulose, calcium polycarbophil)
However, human studies havent confirmed this risk
Our private label GLP-1 Booster formula is strategically developed to allow partners to enter this high-growth category quickly, professionally, and with a clinically positioned product that resonates with modern weight-management consumers
Patients may present with: Recurrent nosebleeds Heavy menstrual bleeding Easy bruising Gastrointestinal bleeding Surgical bleeding complications Iron deficiency anaemia Chronic fatigue The complexity of VWD contributes to these diagnostic challenges
Patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN2) are contraindicated from GLP-1 therapy